Prenatal valve formation in congenital heart disease
Prenatal valve formation in congenital heart disease
批准号:
10716712
负责人:
Sandra Rugonyi
金额:
$38.5万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2027-04-30
关键词:
3-DimensionalAddressAffectAortaArteriesBirdsBirthBloodBlood flowCardiacCell Differentiation processCellsCharacteristicsChemicalsChickChick EmbryoCollagenCollagen FiberCompetenceComputer ModelsConfocal MicroscopyCongenital atresia of pulmonary valveCuesDataDepositionDevelopmentDiameterEchocardiographyElastinElastin FiberEmbryoEventExhibitsExtracellular MatrixFaceFetal DevelopmentFetal HeartFetusFunctional disorderFutureHeartHeart ValvesHumanImageImpairmentInterventionKnowledgeLeft ventricular structureLifeLongitudinal StudiesLungMapsMicroscopyModelingMorphologyNatural regenerationNewborn InfantOperative Surgical ProceduresOrganPathologicPatternPredispositionProcessPulmonary Valve StenosisPulmonary artery structureResolutionRight ventricular structureScanning Electron MicroscopySideSmooth Muscle MyocytesStructureSurfaceTestingTetralogy of FallotTimeTissuesVentricular Septal Defectscongenital heart disorderexperiencefetalfetal diagnosishatchingheart functionheart imaginghemodynamicsimaging modalityimprovedin vivoin vivo imaginglight microscopymathematical modelmicroCTnovelpredictive modelingprenatalresponsesemilunar valveshear stresstreatment strategyvalve replacement
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
Tetralogy of Fallot (TOF) is a critical congenital heart malformation that typically requires intervention soon
after birth and affects about 1,660 newborns per year in the US. In TOF, blood flow through the pulmonary
artery is reduced or blocked (due to pulmonary stenosis or atresia), while blood flow through the aorta is
increased. Prenatally, TOF-induced abnormal blood flow progressively leads to pathological cardiac valve
tissue remodeling. The semilunar (aortic and pulmonary) valve leaflets and the great arteries (the aorta and
pulmonary artery) are particularly susceptible to abnormal blood flow. This is because fetal stages are a critical
time when extracellular matrix components that dictate valve integrity and function, such as collagen and
elastin, deposit and organize within valve tissues, and smooth muscle cells are differentiating and organizing in
supporting arteries. However, how semilunar valves and great arteries remodel in response to TOF-induced
abnormal hemodynamic loads during fetal stages remains unknown.
To address this knowledge gap, this project will use a chick embryonic model of TOF that reproduces the
characteristic heart morphologies and flow patterns found in human fetuses with TOF. Avian embryos are
amenable to in vivo imaging and allow tightly controlled longitudinal studies in ovo. Moreover, valve leaflets in
human and chick exhibit the same characteristic layers, which similarly arrange in response to blood flow cues
during fetal development in human and pre-hatching in chick. The overarching hypothesis of this proposal is
that before birth abnormal blood flow in TOF leads to aberrant, disorganized deposition of collagen and elastin
fibers in semilunar valve leaflets, and abnormal smooth muscle cell localization in supporting great artery
tissues. Three aims are proposed: 1) Determine characteristic blood flow patterns in fetal hearts with TOF
using advanced in vivo imaging and computational modeling; 2) Assess abnormal tissue remodeling
of semilunar valves and great arteries in TOF through a combination of advanced multiscale
microscopy; 3) Develop predictive models of flow-induced semilunar valve remodeling in TOF.
Through a novel combination of multiscale imaging and computational modeling, this project will elucidate how
TOF-induced abnormal blood flow leads to (and exacerbates) semilunar valve and great artery tissue
anomalies. In the future, findings from this project will improve fetal diagnosis and prediction of prenatal
pathological valve remodeling, enabling better decisions of when and how to intervene to avoid or even
reverse pathological valve remodeling, and will inform valve regeneration efforts.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3390/jcdd10100411
发表时间:
2023-09-27
期刊:
Journal of cardiovascular development and disease
影响因子:
2.4
作者:
[Baenen O, Carreño-Martínez AC, Abraham TP, Rugonyi S]
通讯作者:
Rugonyi S
Dynamic changes in the chick developing heart in response to altered hemodynamics
-
批准号:8691986
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2009
-
负责人:Sandra Rugonyi
-
依托单位:
Dynamic changes in the chick developing heart in response to altered hemodynamics
-
批准号:8822318
-
项目类别:
-
资助金额:$40.72万
-
财政年份:2009
-
负责人:Sandra Rugonyi
-
依托单位:
Dynamic changes in the chick developing heart in response to altered hemodynamics
-
批准号:7788224
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2009
-
负责人:Sandra Rugonyi
-
依托单位:
Dynamic changes in the chick developing heart in response to altered hemodynamics
-
批准号:7837327
-
项目类别:
-
资助金额:$20.3万
-
财政年份:2009
-
负责人:Sandra Rugonyi
-
依托单位:
Dynamic changes in the chick developing heart in response to altered hemodynamics
-
批准号:7662787
-
项目类别:
-
资助金额:$36.73万
-
财政年份:2009
-
负责人:Sandra Rugonyi
-
依托单位:
Dynamic changes in the chick developing heart in response to altered hemodynamics
-
批准号:8055060
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2009
-
负责人:Sandra Rugonyi
-
依托单位:
Dynamic changes in the chick developing heart in response to altered hemodynamics
-
批准号:8235869
-
项目类别:
-
资助金额:$37.66万
-
财政年份:2009
-
负责人:Sandra Rugonyi
-
依托单位:
Dynamic changes in the chick developing heart in response to altered hemodynamics
-
批准号:9236209
-
项目类别:
-
资助金额:$41.44万
-
财政年份:2009
-
负责人:Sandra Rugonyi
-
依托单位:
Dynamic changes in the chick developing heart in response to altered hemodynamics
-
批准号:8504451
-
项目类别:
-
资助金额:$40.56万
-
财政年份:2009
-
负责人:Sandra Rugonyi
-
依托单位:
海外基金